RECITE this mantra in chemotherapy-induced thrombocytopenia : treat patients, not platelets

Bron
Nature Reviews Clinical Oncology - ISSN 1759-4774- (2026) p.
Auteur(s)

Inferior control arms in oncology trials in LMICs : contextualised or compromised?

Bron
BMJ oncology - ISSN 2752-7948-4:1 (2025) p. 1-2
Auteur(s)

Overall survival assessment in cancer drug trials : a luxury or a necessity?

Bron
The lancet oncology - ISSN 1470-2045-26:11 (2025) p. 1402-1404
Auteur(s)

Success in oncology phase 3 trials : a small P value or patient value

Bron
Journal of the National Cancer Institute - ISSN 0027-8874-117:9 (2025) p. 1761-1763
Auteur(s)

Assessing clinical value of new treatment strategies : ESMO-MCBS and ASCO-VF evaluation in phase III trials at ASCO Annual Meeting 2022

Bron
JCO oncology practice - ISSN 2688-1527-21:9 (2025) p. 1-11
Auteur(s)